BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND CgA AND Staging
6 results:

  • 1. Chromogranin A--serum marker for prostate cancer.
    Khan MO; Ather MH
    J Pak Med Assoc; 2011 Jan; 61(1):108-11. PubMed ID: 22368921
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Serum tPSA, cPSA, related density parameters and chromogranin A as predictors of positive margins after radical prostatectomy.
    Custovic Z; Kraus O; Tomaskovic I; Tarle M
    Anticancer Res; 2007; 27(4C):2817-21. PubMed ID: 17695453
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The possible role of chromogranin A as a prognostic factor in organ-confined prostate cancer.
    Grimaldi F; Valotto C; Barbina G; Visentini D; Trianni A; Cerruto MA; Zattoni F
    Int J Biol Markers; 2006; 21(4):229-34. PubMed ID: 17177161
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Combined assay of serum prostate specific antigen and chromogranin A helps diagnosis of prostate cancer].
    Sun CC; Zheng W; Kong CZ; Wang X; Yang CM
    Zhonghua Nan Ke Xue; 2006 Oct; 12(10):904-5, 909. PubMed ID: 17121020
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Geriatric assessment in elderly patients with prostate cancer.
    Terret C; Albrand G; Droz JP
    Clin Prostate Cancer; 2004 Mar; 2(4):236-40. PubMed ID: 15072607
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Chromogranin A and B and secretogranin II in prostatic adenocarcinomas: neuroendocrine expression in patients untreated and treated with androgen deprivation therapy.
    Pruneri G; Galli S; Rossi RS; Roncalli M; Coggi G; Ferrari A; Simonato A; Siccardi AG; Carboni N; Buffa R
    Prostate; 1998 Feb; 34(2):113-20. PubMed ID: 9465942
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.